A method to increase protein secretion levels in filamentous fungi

By knocking out the An01g09210 gene in Aspergillus niger strains using CRISPR-Cas9 gene editing technology, recombinant strains were constructed, overcoming the bottleneck of traditional screening and breeding methods. This improved the secretion capacity and activity of saccharifying enzymes and α-amylases, meeting industrial needs.

CN114686509BActive Publication Date: 2026-11-10SHANDONG LONGKETE ENZYME PREPARATION +1
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202011604138.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-12-30
Publication Date
2026-11-10
Estimated Expiration
2040-12-30

AI Technical Summary

Technical Problem

Existing technologies have limitations in improving the protein secretion levels of filamentous fungi, particularly the production capacity of saccharifying enzymes and α-amylases. Traditional screening and breeding methods are time-consuming and labor-intensive, making it difficult to meet industrial demands.

Method used

By knocking out the gene An01g09210 in Aspergillus niger strain using CRISPR-Cas9 genome editing technology, a recombinant strain was constructed, which enhanced the protein secretion pathway and improved the secretion capacity of saccharifying enzymes and α-amylases.

Benefits of technology

It significantly improved protein secretion levels, increased saccharifying enzyme activity by 36%, and increased α-amylase activity by 24%, reducing the cost and time of traditional screening breeding.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure HDA0002872507030000011
    Figure HDA0002872507030000011
  • Figure HDA0002872507030000012
    Figure HDA0002872507030000012
Patent Text Reader

Abstract

This invention discloses a method for enhancing the secretion of proteins by Aspergillus and a recombinant strain obtained by the method. The method involves genetically manipulating Aspergillus cells to delete or reduce the activity of specific genes, thereby enhancing their secretion capacity of proteins such as saccharifying enzymes, α-amylase, and other proteins involved in starch hydrolysis. In a specific experiment, this invention utilizes CRISPR-Cas9 editing technology to knock out the An01g09210 gene in Aspergillus niger, obtaining a gene-edited deletion mutant strain. This mutant strain significantly enhances the production level of starch hydrolytic enzymes, with protein secretion levels increasing by approximately 33% compared to the original strain, saccharifying enzyme activity increasing by approximately 36%, and α-amylase activity increasing by approximately 24%, demonstrating significant application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the fields of genetic engineering and biotechnology. Specifically, this invention relates to a method for increasing the secretion level of Aspergillus protein, specifically involving genetic modification of Aspergillus, and more specifically involving the deletion and editing of the gene An01g09210 in the Aspergillus genome. Background Technology

[0002] Filamentous fungi protein production systems possess enormous development potential and broad patent prospects. As cell factories, they can efficiently express and secrete extracellular proteins, producing valuable products (such as industrial enzymes and organic acids). Many filamentous fungi, such as Aspergillus niger (…),… Aspergillus niger ) and Aspergillus oryzae ( Aspergillus oryzae ) and Trichoderma reesei ( Trichoderma reesei These bacteria have been certified by the FDA (Food and Drug Administration) and are internationally recognized as Generally Recognized As Safe (GRAS), and are widely used in the production of industrial proteins.

[0003] Glucoamylase (EC 3.2.1.3), also known as glucoamylase, is widely used in industries requiring the maximum conversion of starch into glucose, such as beer, monosodium glutamate (MSG), starch sugars, and antibiotics. It is one of the most important enzymes in industrial production. The main producing strains of glucoamylase are molds, with *Aspergillus niger*, *Monascus purpureus*, and *Rhizopus* being commonly used in my country. In my country, glucoamylase is primarily refined from superior strains of *Aspergillus niger* through deep fermentation. After decades of continuous development, my country's starch processing enzyme industry is now capable of independently producing bulk enzyme preparations such as saccharifying enzymes. For example, Chinese patent CN 105255741A discloses a high-saccharifying enzyme strain, Aspergillus niger CGMCC 10788, obtained through multiple rounds of protoplast electrofusion breeding using Aspergillus niger G131 and F285 as starting strains. The average fermentation enzyme activity of this strain can reach 87,000-90,000 u / mL, which is 99.3% higher than that of the starting strain. Invention patent CN 105969675A discloses a high-saccharifying enzyme Aspergillus niger strain. This mutant strain increases the enzyme activity of saccharifying enzyme by inactivating the expression of α-glucosidase. Invention patent CN 103937766A discloses a method to improve saccharifying enzyme by site-directed integration of a saccharifying enzyme expression cassette and a selection marker gene into the An12g08830 locus of Aspergillus niger.

[0004] Although these studies have reached a high level, current research mainly focuses on screening and breeding high-yielding saccharifying enzyme strains using traditional strain selection methods, or increasing the copy number of saccharifying enzyme genes or removing transglycoses in existing Aspergillus niger strains. Saccharifying enzyme synthesis and secretion involve multiple systems, including transcriptional regulation, translation, folding modification, transport, and secretion through the cell membrane, making it a highly complex process. However, developing high-yielding saccharifying enzyme strains requires more than just increasing the RNA abundance of saccharifying enzyme genes at the expression level; it also necessitates further understanding the effects of saccharifying enzymes during secretion, mitigating or even eliminating bottlenecks in the secretion pathway, and further enhancing the protein secretion capacity of filamentous fungi.

[0005] Therefore, it is necessary to develop a method to improve protein secretion levels by modifying the secretion pathway, and to use gene editing technology to obtain recombinant strains with significantly improved secretion levels of starch hydrolases such as saccharifying enzymes. This would reduce the time and labor costs required by traditional screening and breeding, and meet the needs of saccharifying enzymes for fermentation applications in the industrial field in my country. This is an important innovation. Summary of the Invention

[0006] Through extensive and in-depth research, the inventors aim to provide a strain modification method that can improve the production capacity of amylase and the protein secretion level of filamentous fungi. This method involves genetically modifying genes related to the protein secretion pathway in filamentous fungi to increase amylase production and protein secretion levels. In this invention, the An01g09210 gene in Aspergillus niger strain was knocked out using CRISPR-Cas9 genome editing technology, resulting in a recombinant strain with the An01g09210 gene deletion. This recombinant strain significantly enhances protein secretion levels and significantly increases the production capacity and activity of saccharifying enzymes and α-amylases.

[0007] To achieve this objective, the present invention adopts the following technical solution: The first aspect of this invention provides a method for obtaining a gene-deleted mutant strain of Aspergillus niger by genetic modification technology. This mutant strain is obtained by gene knockout of Aspergillus niger using CRISPR-Cas9 genome editing technology. The construction method includes the following steps: constructing two guide RNA (sgRNA) expression elements targeting the gene An01g09210, with nucleotide sequences shown in SEQ ID NO.3 (AnU6p-An01g09210-sgRNA-1) and SEQ ID NO.4 (AnU6p-An01g09210-sgRNA-2), respectively; and constructing a homologous donor DNA sequence for the gene An01g09210 containing the G418 resistance marker, with a nucleotide sequence shown in SEQ ID NO.5 (donor-An01g09210). After co-transforming the expression cassettes of the Cas9 protein, AnU6p-An01g09210-sgRNA-1 and AnU6p-An01g09210-sgRNA-2, and the donor DNA donor-An01g09210 into the protoplasts of the host strain, gene-edited mutant strains can be obtained through homologous recombination.

[0008] On the other hand, the present invention provides a recombinant strain for producing saccharifying enzymes, α-amylases, or other starch hydrolases, which, compared with the starting strain, exhibits stronger secretion capacity for saccharifying enzymes, α-amylases, or other starch hydrolases, and stronger ability to hydrolyze starch. The recombinant strain is a gene-mutant strain named ΔAn01g09210, which is an Aspergillus strain with the An01g09210 gene knocked out. More specifically, the present invention provides a recombinant Aspergillus niger strain with enhanced secretion of saccharifying enzymes or α-amylases, obtained by gene editing of the An01g09210 gene in Aspergillus niger using the gene editing method of the present invention to obtain a recombinant Aspergillus niger strain with the An01g09210 gene deletion mutation.

[0009] The host cell is Aspergillus. In a more specific embodiment, the host cell is selected from, but not limited to, the Aspergillus genus, with Aspergillus niger being the most preferred.

[0010] In this invention, the meanings of the terms used are explained.

[0011] When "recombinant" is used to refer to a strain, cell, nucleic acid, protein, or vector, it indicates that the strain, cell, nucleic acid, protein, or vector has been modified by introducing a foreign nucleic acid or protein or by altering the native nucleic acid or protein. For example, a recombinant strain expresses a gene not found in the native (non-recombinant) form of the strain, or expresses a native gene.

[0012] "Host strain" or "host cell" refers to a suitable host for the expression vector or DNA construct. Specifically, the host strain is preferably Aspergillus, and most preferably Aspergillus niger. The host cell can be an Aspergillus host cell or a genetically modified host cell.

[0013] "Genome editing" refers to the deletion, insertion, or replacement of genomic DNA in an organism to modify the target sequence.

[0014] "CRISPR-Cas9 editing technology" refers to the ability of the Cas9 protein, guided by sgRNA, to cut specific DNA sequences in the genome of an organism, creating DNA double-strand breaks. This triggers the cell's own repair mechanisms to perform non-homologous end joining (NHEJ) or homologous recombination (HR) repair at the DSB site, thereby achieving gene knockout, gene inactivation, gene knock-in, and gene replacement, and realizing the goal of efficient genome editing.

[0015] The "target site" or "protospacer" refers to a portion of the nucleic acid sequence that defines the target DNA. Specifically, it refers to the 20-base sequence at the 5' end of the guide RNA (sgRNA). This sequence is identical to the target DNA sequence. Under sufficient conditions for binding, the sgRNA requires this sequence to bind to the target DNA. The Cas9-sgRNA complex then cleaves the target DNA.

[0016] A “sequence” refers to a nucleotide sequence of any suitable length, which can be DNA or RNA; it can be linear, circular, or branched, and it can be single-stranded or double-stranded. The term “donor DNA sequence” refers to the nucleotide sequence that is inserted into the genome. The donor sequence can be of any length, for example, preferably between about 500 and 3,000 nucleotides (or any integer value between them).

[0017] This invention achieves the following beneficial effects: genetic manipulation of Aspergillus cells to delete or reduce the activity of the An01g09210 gene significantly enhances the production level of starch hydrolase. In a specific experiment, this invention utilizes CRISPR-Cas9 editing technology to knock out the An01g09210 gene in Aspergillus niger, obtaining a gene-edited deletion mutant strain. This mutant strain significantly enhances the production level of starch hydrolase, with protein secretion increasing by approximately 33% compared to the original strain, saccharifying enzyme activity increasing by approximately 36%, and α-amylase activity increasing by approximately 24%, demonstrating significant application value. Attached Figure Description

[0018] Figure 1 This is a schematic diagram illustrating the knockout of the target gene An01g09210 using CRISPR-Cas9 editing technology.

[0019] Figure 2 The image shows the PCR identification of nucleic acid electrophoresis for knocking out the target gene An01g09210 using CRISPR-Cas9 editing technology.

[0020] Figure 3 The protein secretion of Aspergillus niger gene An01g09210 deletion mutant strain and the starting strain WT under starch-induced fermentation conditions.

[0021] Figure 4 This image shows the SDS-PAGE electrophoresis analysis of proteins in the fermentation supernatant of Aspergillus niger gene An01g09210 deletion mutant strain and the starting strain WT under starch-induced conditions.

[0022] Figure 5 The saccharifying enzyme activity of the supernatant from the fermentation of Aspergillus niger gene An01g09210 deletion mutant strain and the starting strain WT under starch-induced conditions was measured.

[0023] Figure 6 The α-amylase activity of the fermentation supernatant of Aspergillus niger gene An01g09210 deletion mutant strain and the starting strain WT under starch-induced conditions was measured. Detailed Implementation

[0024] To further illustrate the technical means and effects of this invention, the following description, in conjunction with preferred embodiments, further explains the technical solution of this invention. It should be understood that these embodiments are for illustrative purposes only and are not intended to limit the scope of this invention. Those skilled in the art should understand that modifications or substitutions to the details and form of the technical solution of this invention can be made without departing from the spirit and scope of this invention, but all such modifications or substitutions fall within the protection scope of this invention.

[0025] Unless otherwise specified, the methods used in the following examples are conventional methods. For specific steps, please refer to: "Molecular Cloning: A Laboratory Manual" (Sambrook, J., Russell, David W., Molecular Cloning: A Laboratory Manual, 3rd edition, 2001, NY, Cold SpringHarbor).

[0026] The methods for obtaining various biological materials described in the embodiments are merely to provide experimental methods for specific disclosure purposes and should not be construed as limiting the sources of biological materials used in this invention. In fact, the sources of biological materials used are wide-ranging, and any biological material that can be obtained without violating laws and ethical standards can be substituted and used according to the suggestions in the embodiments.

[0027] The original starting strain Aspergillus niger CBS513.88 used in the examples was purchased from the Central Bureauvoor Schimmelcultures CBS Fungal Biodiversity Centre and was obtained through commercial channels.

[0028] Unless otherwise specified, specific techniques or conditions in the examples were performed according to the techniques or conditions described in the literature in this field, or according to the product instructions. Reagents or instruments whose manufacturers are not specified were all conventional products that can be purchased through legitimate channels. Unless otherwise specified, all percentage concentrations are mass percentages. Primers and nucleic acid sequencing were performed by GNEWIZ (Suzhou Genewiz Biotechnology Co., Ltd.). "An01g09210" is the gene locus number for Aspergillus niger.

[0029] Example 1: Construction of a CRISPR-Cas9-mediated gene editing vector for Aspergillus niger, An01g09210. (1) Construction of the sgRNA expression cassette vector for gene An01g09210 The target site for the gene An01g09210 was designed using the sgRNACas9 tool. The Aspergillus niger AnU6p promoter, target site, and sgRNA backbone were linked together using fusion PCR, and the sgRNA expression cassette vector was constructed using the gene overlap extension (SOE) method. The primer sequences required for the sgRNA expression cassette vector are shown in Table 1.

[0030] The PCR reaction system consisted of: 10 μL of 5×Phusion HF buffer, 1 μL of 10 mM dNTPs, 2.5 μL of upstream / downstream primers, 1 μL of template DNA, 0.5 μL of Phusion DNA polymerase, and 32.5 μL of ddH2O.

[0031] The PCR reaction conditions were as follows: first 98℃ for 30s; then 98℃ for 10s, 65℃ for 30s, 72℃ for 1min, for 34 cycles; finally 72℃ for 10min, 4℃ for 10min.

[0032] SOE-PCR amplification was used to form sgRNA expression plasmids AnU6p-An01g09210-sgRNA-1 and AnU6p-An01g09210-sgRNA-2, whose sequences are shown in SEQ ID No. 3 and SEQ ID No. 4, respectively.

[0033] (2) Construction of homologous donor DNA vector In this embodiment, the homologous donor DNA fragment was constructed from homologous fragments upstream and downstream (935 bp and 984 bp) of the target gene An01g09210, and the PtrpC-neo fragment of the G418 resistance gene expression cassette. These fragments were ligated into the plasmid pUC118, linearized with restriction endonucleases BamHI and HindIII, using Gibson Assembly. The resulting donor DNA fragment, donor-An01g09210, has the nucleic acid sequence shown in SEQ ID No. 5. The PCR primer sequences required for constructing the donor DNA fragment are shown in Table 1.

[0034] Table 1: Primers used in Example 1

[0035] Example 2: Gene knockout of Aspergillus niger gene An01g09210 using CRISPR-Cas9 system (1) Protoplast transformation of Aspergillus niger A. Mycelial preparation Mature Aspergillus niger spores were collected with 0.05% Tween-80 sterile water, and after filtering out the hyphae with lens paper, they were inoculated into MM liquid culture and cultured at 30℃ and 200rpm for 16h.

[0036] B. Protoplast preparation After collecting the hyphae by filtration, place them in 30 mL of lysis buffer (formula: 0.15 g lysin, 30 mL solution A, filtered and sterilized; Solution A: 1.0361 g potassium dihydrogen phosphate, 21.864 g sorbitol, dissolved in 90 mL deionized water, pH adjusted to 5.6, volumetrically adjusted to 100 mL, and sterilized at high temperature). Incubate at 30 °C for 2 h, gently shaking every 30 min. Then filter through cellophane, centrifuge at 2000 rpm for 10 min at 4 °C, discard the supernatant, add 4 mL of solution B (formula: 0.735 g calcium chloride, 18.22 g sorbitol, 1 mL Tris-HCl (1 M, pH 7.5), dissolved in 90 mL deionized water, pH adjusted to 7.6, volumetrically adjusted to 100 mL, and sterilized at high temperature), centrifuge at 2000 rpm at 4 °C for 10 min; discard the supernatant, and add a certain volume of solution B at 200 μL / plasmid.

[0037] C. Protoplast transformation In a pre-chilled 15 mL centrifuge tube, add 50 μL of pre-chilled PEG (12.5 g PEG6000, 0.368 g calcium chloride, 500 μL Tris HCl (1 M pH 7.5)) sequentially. Mix the DNA fragment to be transformed and add it to 200 μL of protoplasts. Place on ice for 20 min, then add 2 mL of pre-chilled PEG solution and incubate at room temperature for 5 min. Then add 4 mL of solution B and mix gently. Take 3 mL of the above solution and add it to 12 mL of thawed MM medium containing 1.5 mg / mL FOA. Spread the solution evenly on a plate and incubate at 35 °C. After 3 days, pick individual mycelia and grow them on the corresponding antibiotic plates.

[0038] (2) Gene knockout of the An01g09210 site of Aspergillus niger using the CRISPR-Cas9 system. The Cas9 protein expression element p0380-Ptef1-Cas9, along with AnU6p-An01g09210-sgRNA-1 and AnU6p-An01g09210-sgRNA-2 expression elements and homologous donor DNA donor-An01g09210, were mixed in equal proportions and co-transformed into Aspergillus niger CBS513.88 protoplast cells. Figure 1 As shown, Cas9, mediated by sgRNA, identifies and cuts target sites by pairing the target sequence with the DNA strand of the target gene on the host cell genome. Subsequently, homologous recombination occurs between the donor DNA fragment and the sequences flanking the target site, thereby achieving the purpose of genome editing. Transformants are selected by adding G418 to the plate.

[0039] (3) Verification of Aspergillus niger transformants A. Extraction of Aspergillus niger genome Genomic DNA was extracted from transformants selected during the above transformation process using the phenol-chloroform method, specifically including the following steps: 1) Add 200 mg of zirconium beads and 1 mL of lysis buffer (formula: 0.2 M Tris•HCl (pH 7.5), 0.5 M NaCl, 10 mM EDTA, 1% SDS (w / v)) to a 2.0 mL sterile DNA extraction tube, and pick the Aspergillus niger hyphae growing on the plate into the DNA extraction tube. 2) Place all DNA extraction tubes on the grinding aid and oscillate at maximum speed for 30 seconds. Repeat twice. 3) Bathe in a 65℃ water bath for 30 minutes, vortexing every few minutes during the water bath process; 4) After the water bath, remove the tubes and add 80 μL of 1M Tris•HCl (pH 7.5) to each tube to neutralize it; 5) Add 400 μL of phenol:chloroform (1:1) and centrifuge at 13000 rpm for 5 minutes; 6) Take 300 μL of supernatant into a new 1.5 mL EP tube and add 600 μL of 95% ethanol (DNA grade). 7) Incubate on ice for one hour, then centrifuge at 4°C and 13,000 rpm. You will see white DNA precipitate at the bottom of the EP tube. 8) Wash with 400 μL of 75% alcohol (DNA grade), centrifuge at 13000 rpm at 4°C, and gently remove the supernatant; 9) Place the EP tube in a vacuum concentrator to remove residual alcohol; 10) Add 50 μL ddH2O to dissolve the DNA, measure the DNA concentration using NanoDrop, and store the extracted DNA at -20℃ for PCR verification in the next step.

[0040] B. PCR verification of transformants Using the extracted genomic DNA as a template, the transformants were validated by gene PCR using primers An01g09210-ko-F and An01g09210-ko-R. PCR reagents were purchased from Nanjing Novizan Biotechnology Co., Ltd.

[0041] The primer sequences are as follows: An01g09210-ko-F: GGTTCTTCATTCCTGTGTAGTAGCT (SEQ ID No. 18) An01g09210-ko-R: CTGTAGCGCATTGGGCTCTGTATTG (SEQ ID No. 19) The PCR reaction system consisted of: 2 μL of 10×Taq Buffer, 0.2 μL of 10 mM dNTP Mix, 0.4 μL each of upstream and downstream primers, 1 μL of DNA template, 0.2 μL of Taq DNA Polymerase, and 15.8 μL of water.

[0042] The PCR reaction conditions were as follows: first, 94℃ for 5 min; then 94℃ for 30 s, 55℃ for 30 s, 72℃ for 1.2 min, for 30 cycles; finally, 72℃ for 7 min, 4℃ for 10 min. Experimental results: PCR amplification products were subjected to 1% agarose gel electrophoresis (120V, 30 minutes). Clear gene amplification bands were observed under the gel imaging system. The PCR amplification band of the mutant was 1848 bp, and the target band of the wild-type strain was 952 bp. The results are as follows: Figure 2As shown, homologous recombination occurred between the donor DNA fragment and the sequences flanking the target site, resulting in a gene-edited mutant. Of the 23 transformations obtained, 15 were successfully knocked out, achieving a knockout efficiency of 65%.

[0043] Example 3: Analysis of protein secretion levels in gene-edited deletion strains under starch-induced conditions (1) Cultivation of deletion mutant strains in starch-induced medium: The above-obtained gene An01g09210 deletion mutant strains (ΔAn01g09210-1, ΔAn01g09210-2 and ΔAn01g09210-3) and the starting strain CBS513.88 were inoculated into 50 mL of medium in 250 mL Erlenmeyer flasks. Medium formulation: 30 g maltose, 10 g peptone extract, 5 g yeast extract, 1 g KH2PO4, 0.5 g MgSO4, 0.03 g ZnCl2, 0.02 g CaCl2, 0.0076 g MnSO4, 0.3 g FeSO4, 3 mL Tween 80, adjusted to 1000 mL, autoclaved), and the inoculum size was 2.5 g. 10 5 The samples were cultured at 30℃ and 200 rpm for 6 days, and the supernatant was collected by centrifugation. The protein concentration was analyzed by SDS-PAGE electrophoresis.

[0044] (2) Determination of secretory protein concentration: The protein concentration in the supernatant was detected using the Bradford Protein Rapid Test Kit. The results are as follows: Figure 3 As shown, compared with the wild type, the protein production of all mutant strains was significantly increased. Under starch culture conditions, the protein production on day 5 and day 6 was increased by ~26% and ~33%, respectively, compared with the original strain.

[0045] (3) SDS-PAGE electrophoresis detection of supernatant: Based on the protein concentration on day 6, an equal volume of supernatant was taken for 4-12% SDS-PAGE electrophoresis detection. The results are as follows: Figure 4 As shown, compared with the original strain CBS513.88, the corresponding bands of starch hydrolases such as saccharifying enzyme in the mutant were significantly darker, and the secreted protein level (0.52 g / L) was significantly higher than that of the original strain (0.39 g / L), an increase of 33%.

[0046] Example 4: Phenotypic analysis of the production of saccharifying enzymes and α-amylase by gene-edited deletion strains The obtained gene deletion mutant strains An01g09210 (ΔAn01g09210-1, ΔAn01g09210-2, and ΔAn01g09210-3) and the starting strain CBS513.88 were inoculated into 50 mL of culture medium in 250 mL Erlenmeyer flasks. The culture medium formulation was: 30 g maltose, 10 g peptone extract, 5 g yeast extract, 1 g KH2PO4, 0.5 g MgSO4, 0.03 g ZnCl2, 0.02 g CaCl2, 0.0076 g MnSO4, 0.3 g FeSO4, 3 mL Tween 80 (adjusted to a final volume of 1000 mL, autoclaved), with an inoculum size of 2.0 g. 10 5 The samples were cultured at 30℃ and 200 rpm for 6 days, and the supernatant was collected by centrifugation to determine the activities of saccharifying enzyme and α-amylase.

[0047] (1) Assay of glucoamylase activity: The crude enzyme solution was diluted with 0.05 M pH 4.6 sodium acetate buffer to a suitable ratio, with a final volume of 0.25 mL. It was preheated in a 40 ℃ water bath, removed, and 0.25 mL of 1% soluble starch (Difco) substrate solution preheated in a 40 ℃ water bath was added. The mixture was mixed and reacted at 40 ℃ for 10 min. The reaction was terminated with 0.5 mL DNS solution, boiled for 10 min, cooled on ice, and then diluted to 2.5 mL with distilled water. The mixture was shaken well and the amount of glucose released was determined by the DNS method. The OD value was measured at a wavelength of 540 nm. The blank group used inactivated enzyme solution as a control. The definition of saccharifying enzyme activity is: the amount of enzyme that hydrolyzes soluble starch to produce 1 μmol of glucose per minute in 1 mL of enzyme solution at 40 ℃ and pH 4.6, which is one unit of enzyme activity (U).

[0048] The results are as follows Figure 5 As shown, compared with the original strain, the saccharifying enzyme activity of the gene An01g09210 deletion mutant strain (11.8 U / ml) was significantly increased by 36% compared with the original strain (8.7 U / ml).

[0049] (2) α-Amylase activity assay: The activity of α-amylase was determined using Solarbio's amylase activity assay kit (catalog number: BC0610). The crude enzyme solution was diluted with 0.05M pH 6.0 phosphate buffer to a suitable ratio, with a final volume of 0.25 mL. It was placed in a 70 ℃ water bath for 15 min to passivate. After that, 0.25 mL of starch substrate reagent preheated in a 40 ℃ water bath was added, mixed well, and reacted at 40 ℃ for 5 min. The reaction was terminated with 0.5 mL of DNS solution, boiled for 10 min, cooled on ice, and then diluted to 2.5 mL with distilled water. The mixture was shaken well, and the amount of reducing sugar released was determined by the DNS method. The OD value was measured at a wavelength of 540 nm. The blank group used inactivated enzyme solution as a control. α-Amylase activity is defined as the amount of enzyme that hydrolyzes soluble starch to produce 1 mg of reducing sugar per minute in 1 mL of enzyme solution at 40 ℃ and pH 6.0, which is one unit of enzyme activity (U).

[0050] The results are as follows Figure 6 As shown, compared with the original strain, the α-amylase activity of the gene An01g09210 deletion mutant strain (13.4 U / ml) was increased by 24% compared with the original strain (10.8 U / ml). sequence list <110> Shandong Longket Enzyme Preparations Co., Ltd., Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences <120> A method to increase protein secretion levels in filamentous fungi <160> 19 <170> PatentIn Version 3.1 <210> 1 <211> 660 <212> PRT <213> Aspergillus niger <400> 1 MTTSAYYVTP PPVGIGCLRH HERPVTDLSS SSNPIVEQVY RSRPPSASAI LPLYNAYAAP 60 RPSLIYFPNT TPPVTVFSVV QSNLLFLALS EVDTEPLLAL EFIHRVVDVL EDFVGAPLLS 120 TKIQANYDVV AQLLHEMCDA GIVCNTEPNA LQEVVEMPGW MGKLLGGVGL PGSSTPILGQ 180 PSAMKQSAAA ATQGPAIPWR KSGVRHTSNE LYVDIIESLS VTMAPSGRLL SAMSSGTIAF 240 TAKISGVPDL LLSLTAPGGQ KALGRKLELP VFHPCVRLAR WREHPGELSF VPPDGRFILA 300 GYEVDLMPTD PTLDQPPSHM EKLFLPAIVD IRKSLGPTGS DFEVRLILNT NFPGYSSSNR 360 PGVGRSGSGT STPSFLGGGG GNSSAPVLEE VVVSVPIPKS VRNITDMQAS RGEALFSPGN 420 GVLEWRVPTK DAGTISGTAT LRCTVVGHYA DDELDDDVEE LDADTNLLQG YYDASASYQN 480 PEADTTKRKT KKKKKKKVVK KSSSRAAAAA AAAEAEASAS SPAEHLSLNP EDPEQLEHTP 540 TPEPEQSQTL TPPVQSSSPQ PPPSLPRSQS QSQKQSPSRA YSDSSIFLSA PRKTKTQLNA 600 TLMPNSAAVS FSVRGWLPSG LKVESLNIDP RRSRGLGEGV KPYKGVKYIC MSRKGVERRC 660 <210> 2 <211> 1983 <212> DNA <213> Aspergillus niger <400> 2 atgaccacct ctgcctacta cgttacgccc ccaccggtcg ggataggttg ccttcgccat 60 catgagcggc cagtcactga cctgtcctct tccagcaatc cgatcgtcga gcaggtctat 120 cgctcccgtc cgccctccgc atcggccatt cttcccctct ataatgccta tgcagctccg 180 cgcccatcac tcatctactt tccaaataca actccgccgg tgacagtgtt ttcggtagtg 240 cagtccaacc tactgttttt ggcgctgtcc gaggttgaca cggaaccgct gcttgccctg 300 gaattcattc atcgggttgt tgatgttctc gaggacttcg tcggggcacc tttgctttcc 360 accaagatcc aggcgaatta tgatgtggtt gcacagcttc tgcacgaaat gtgcgatgcg 420 gggattgtct gcaatacaga gcccaatgcg ctacaggagg tagtggaaat gccggggtgg 480 atggggaagc tgttaggcgg cgttggattg cctgggtcat ccacaccgat tctgggacaa 540 cccagtgcca tgaagcaatc agccgccgcc gcgacccaag gacctgcgat cccctggaga 600 aagtccggag taagacacac ttccaacgag ctatatgttg atattattga gtcactttcc 660 gtgacgatgg cgccatcagg acgactgctc tctgcaatgt cttccggtac tatcgccttc 720 accgccaaaa tatccggtgt acccgatctg cttctttcgt taacagcgcc cggtggtcag 780 aaagccttgg gacgcaagct ggagctgccg gtatttcacc catgtgtgcg cttggcgcgc 840 tggcgggagc accctggcga gctcagtttt gtaccaccag acggtcggtt cattcttgcc 900 ggatacgagg tggacctcat gccaacagac cctacacttg atcaaccccc gagtcatatg 960 gagaagcttt tcttgccggc tattgtggac atccgtaaat cgcttgggcc gactggctca gacttcgagg tccgccttat tctcaacaca aacttcccgg gatactcatc ctctaaccga cctggggtcg ggcgtagcgg atcaggcacg tctacaccct ctttcctcgg gggtggaggc 1140 ggcaactcct cggcgccagt gctagaagag gttgtggtga gcgtcccgat cccgaagtcg gtccggaaca tcacagacat gcaagccagc cgaggagagg ctttattctc accgggcaac ggcgtattag aatggcgcgt gccgactaaa gatgccggca caatctccgg aacggcgaca ctccggtgca ccgtcgtagg acactacgcg gatgacgagc tggacgacga cgtcgaagaa ctcgacgcag acaccaacct cctgcagggc tactacgacg ccagcgcgtc ttaccagaac cctgaagcag acacgacga acgcaagact aagaaaaaga agaagaaga ggttgtcaag aaatcttctt cccgcgcagc ggcagcggca gcggcagcag aagcagaagc ctcagcttcc 1560 tcgcccgctg aacacctttc cttgaacccc gaggatcccg aacaactcga acatacgcct 1620 actcctgaac ccgaacaatc ccagacgcta acaccccccg ttcaatcatc ttcgccgcaa 1680 cctccaccgt cacttccccg gtcacagtca cagtcgcaga aacaatcacc cagccgagct 1740 tactctgatt cctccatctt cctttcggcg ccccgtaaaa ccaagaccca actaaacgcg 1800 acacttatgc ctaattcggc ggctgtgtcg ttctctgtcc gtggctggct tccctcgggg 1860 ctcaaggtag agagcctgaa catcgatccg cggcggagtc gcggactagg cgagggagtg 1920 aaaccatata agggagtgaa atatatctgt atgagtcgga agggagtgga gcggagatgc 1980 tag 1983 <210> 3 <211> 625 <212> DNA <213> Artificial sequence <400> 3 cagttactta taagcttgga gcttggatct ctttgaggtg gaccttcctt gaagggtttc 60 atctctgtac tatcatgcga atgctaaagc agaactttaa cagaaccacc agtgtctaat 120 aaattcgatc cgtatattgt gcaccattac tcatctgtgt ttcccccaaa catgcagtct 180 cctgcgcaga tagactgtca actatagtaa ttcccgtccg cgaagccgcc ctatccaaaa 240 gtgtattacc ctctcttgta tgcaacaaga gtcgttcttt ctcgcgctaa tacccatccg 300 tctatcgcac aattaaacct tctgatccct acaatttgcc tgacaaaata aatgaagttc 360 aacgtgcaaa caagctagag ccagtgtaca ttgagtatca tctgcagctc tactcaaggt 420 actatagtac ctcagccaat ttgatgttcc tgccttcccg cccctcgctt agccgaccaa 480 ttagagttcg ttaattctaa ccattattcc tatataattc aaagttgcct tcgccatcat 540 gaggttttag agctagaaat agcaagttaa aataaggcta gtccgttatc aacttgaaaa 600 agtggcaccg agtcggtgct ttttt 625 <210> 4 <211> 625 <212> DNA <213> Artificial sequence <400> 4 cagttactta taagcttgga gcttggatct ctttgaggtg gaccttcctt gaagggtttc 60 atctctgtac tatcatgcga atgctaaagc agaactttaa cagaaccacc agtgtctaat 120 aaattcgatc cgtatattgt gcaccattac tcatctgtgt ttcccccaaa catgcagtct 180 cctgcgcaga tagactgtca actatagtaa ttcccgtccg cgaagccgcc ctatccaaaa 240 gtgtattacc ctctcttgta tgcaacaaga gtcgttcttt ctcgcgctaa tacccatccg 300 tctatcgcac aattaaacct tctgatccct acaatttgcc tgacaaaata aatgaagttc 360 aacgtgcaaa caagctagag ccagtgtaca ttgagtatca tctgcagctc tactcaaggt 420 actatagtac ctcagccaat ttgatgttcc tgccttcccg cccctcgctt agccgaccaa 480 ttagagtcg ttaattctaa ccattattcc tatataattc aaaggcgctg tccgaggttg 540 acagttttag agctagaaat agcaagttaa aataaggcta gtccgttatc aacttgaaaa 600 agtggcaccg agtcggtgct tttt625 <210> 5 <211> 3120 <212> DNA <213> Aspergillus niger <400> 5 tgggccacgg atcatttttc ctaagtcatc ttcatcctat ccttgtgctc atattctctt 60 tgttacatc ttctcctttt catatcccca ttttcttcgg tcatcattac tattaaatat 120 agaggttatc agacatggcg atacccggtg aggcggctag tgatatatta atcgtacgat 180 cctttctata taatgttttg cacatgtttt gtgaattgtg aagcgcttga ctaagttgat 240 gtgcattccc gtcaacgaaa gacccaacgc ctgagtagaa tatggtataa agtacataat 300 atacaaaatt tcccggcttc atcagttgaa ggctctccat aatcccattc caaccagtgt 360 cgcagagatg gtgaagatcc cgagttgtcg agatcccatc ttatactttg ttgcgctttg 420 catgattgcc ttttcttgca tcttgaggtt cttcattcct gtgtagtagc tatacacacc 480 gaggccgacg aatgcagcag atcctgtaag tcatcggatt agctatagta ccatagtgaa 540 cgcccggaaa caaaaagtag cctaccagta actctgcacg ccaggcagtc atcatatgcg 600 tcctccgcaa gtgcacgctt cgcatccttg ggctggacat ccaaggcgct gtgattctgg 660 atagagggag acattgttct agaatcaacg aaagccaaga aaggtctatt agagagcagt 720 ccagacgagt ctcgatcaag gagactagct tgttgcggcg agctgcagca attcaaagga 780 aatgcatcag aaggcgggga tcggcggcag aacgaggggc ttttggactc cactaaatgg 840 gggccgatag atcaccgacc atcattgctg caccatgacc acctctgcct actacgttac 900 gcccccaccg gtcgggatag gttgccttcg ccatcgttta aaccgacgtt aactgatatt 960 gaaggagcat ttttgggct tggctggagc tagtggaggt caacaatgaa tgcctatttt 1020 ggttagtcg tccaggcggt gagcacaaaa tttgtgtcgt ttgacaagat ggttcattta 1080 ggcaactggt cagatcagcc ccacttgtag cagtagcggc ggcgctcgaa gtgtgactct 1140 tattagcaga caggaacgag gacattatta tcatctgctg cttggtgcac gataacttgg 1200 tgcgtttgtc aagcaaggta agtggacgac ccggtcatac cttcttaagt tcgcccttcc 1260 tccctttatt tcagattcaa tctgacttac ctattctacc caagcatcca aatgattgaa 1320 caagatggat tgcacgcagg ttctccggcc gcttgggtgg agaggctatt cggctatgac 1380 tgggcacaac agacaatcgg ctgctctgat gccgccgtgt tccggctgtc agcgcagggg 1440 cgcccggttc ttttgtcaa gaccgacctg tccggtgccc tgaatgaact gcaagacgag 1500 gcagcgcggc tatcgtggct ggccacgacg ggcgttcctt gcgcagctgt gctcgacgtt 1560 gtcactgaag cgggaaggga ctggctgcta ttgggcgaag tgccggggca ggatctcctg 1620 tcatctcacc ttgctcctgc cgagaaagta tccatcatgg ctgatgcaat gcggcggctg 1680 catacgcttg atccggctac ctgcccattc gaccaccaag cgaaacatcg catcgagcga 1740 gcacgtactc ggatggaagc cggtcttgtc gatcaggatg atctggacga agagcatcag 1800 gggctcgcgc cagccgaact gttcgccagg ctcaaggcga gcatgcccga cggcgaggat 1860 ctcgtcgtga cccatggcga tgcctgcttg ccgaatatca tggtggaaaa tggccgcttt 1920 tctggattca tcgactgtgg ccggctgggt gtggcggacc gctatcagga catagcgttg 1980 gctacccgtg atattgctga agagcttggc ggcgaatggg ctgaccgctt cctcgtgctt 2040 tacggtatcg ccgctcccga ttcgcagcgc atcgccttct atcgccttct tgacgagttc 2100 ttctgaggta ccctgcagcg gaaccgctgc ttgccctgga attcattcat cgggttgttg 2160 atgttctcga ggacttcgtc ggggcacctt tgctttccac caagatccag gcgaattatg 2220 atgtggttgc acagcttctg cacgaaatgt gcgatgcggg gattgtctgc aatacagagc 2280 ccaatgcgct acaggaggta gtggaaatgc cggggtggat ggggaagctg ttaggcggcg 2340 ttggattgcc tgggtgagtg cccaccgtta cgggatggag gtcaccatac tatttacagt 2400 gaactgacgg ccttcgttat gcgcaggtca tccacaccga ttctgggaca acccagtgcc 2460 atgaagcaat cagccgccgc cgcgacccaa ggacctgcga tcccctggag aaagtccgga 2520 gtaagacaca cttccaacga gctatatgtt gatattattg agtcactttc cgtgacgatg 2580 gcgccatcag gacgactgct ctctgcaatg tcttccggta ctatcgcctt caccgccaaa 2640 atatccggtg tacccgatct gcttctttcg ttaacagcgc ccggtggtca gaaagccttg 2700 ggacgcaagc tggagctgcc ggtatttcac ccatgtgtgc gcttggcgcg ctggcgggag 2760 caccctggcg agctcagttt tgtaccacca gacggtcggt tcattcttgc cggatacgag 2820 gtggacctca tgccaacaga ccctacactt gatcaacccc cgagtcatat ggagaagctt 2880 ttcttgccgg ctattgtgga catccgtaaa tcgcttgggc cgactggctc agacttcgag 2940 gtccgcctta ttctcaacac aaacttcccg ggatactcat cctctaaccg acctggggtc 3000 gggcgtagcg gatcaggcac gtctacaccc tctttcctcg ggggtggagg cggcaactcc 3060 tcggcgccag tgctagaaga ggttgtggtg agcgtcccga tc 3102 <210> 6 <211> 25 <212> DNA <213> Artificial sequence <400> 6 cagttactta taagcttgga gcttg 25 <210> 7 <211> 20 <212> DNA <213> Artificial sequence <400> 7 aaaaagcacc gactcggtgc 20 <210> 8 <211> 53 <212> DNA <213> Artificial sequence <400> 8 tctaaaacct catgatggcg aaggcaactt tgaattatat aggaataatg gtt 53 <210> 9 <211> 53 <212> DNA <213> Artificial sequence <400> 9 aattcaaagt tgccttcgcc atcatgaggt tttagagcta gaaatagcaa gtt 53 <210> 10 <211> 53 <212> DNA <213> Artificial sequence <400> 10 tctaaaactg tcaacctcgg acagcgcctt tgaattatat aggaataatg gtt 53 <210> 11 <211> 53 <212> DNA <213> Artificial sequence <400> 11 aattcaaagg cgctgtccga ggttgacagt tttagagcta gaaatagcaa gtt 53 <210> 12 <211> 60 <212> DNA <213> Artificial sequence <400> 12 atgattacga attcgagctc ggtacccggg gatcctgggc cacggatcat ttttcctaag 60 <210> 13 <211> 60 <212> DNA <213> Artificial sequence <400> 13 atgctccttc aatatcagtt aacgtcggtt taaacgatgg cgaaggcaac ctatcccgac 60 <210> 14 <211> 60 <212> DNA <213> Artificial sequence <400> 14 gtcgggatag gttgccttcg ccatcgttta aaccgacgtt aactgatatt gaaggagcat 60 <210> 15 <211> 64 <212> DNA <213> Artificial sequence <400> 15 aattccaggg caagcagcgg ttccgctgca gggtacctca gaagaactcg tcaagaaggc 60 gata 64 <210> 16 <211> 64 <212> DNA <213> Artificial sequence <400> 16 tatcgccttc ttgacgagtt cttctgaggt accctgcagc ggaaccgctg cttgccctgg 60 aatt 64 <210> 17 <211> 58 <212> DNA <213> Artificial sequence <400> 17 cgacgttgta aaacgacggc cagtgccaag cttgatcggg acgctcacca caacctct 58 <210> 18 <211> 25 <212> DNA <213> Artificial sequence <400> 18 ggttcttcat tcctgtgtag tagct 25 <210> 19 <211> 625 <212> DNA <213> Artificial sequence <400> 19 ctgtagcgca ttgggctctg tattg 25

Claims

1. A method for improving the growth of Aspergillus niger ( Aspergillus niger The method for measuring protein secretion levels is characterized by, The gene An01g09210 in Aspergillus niger was knocked out. The protein is a saccharifying enzyme and / or α-amylase. The amino acid sequence of the protein encoded by the gene An01g09210 is shown in SEQ ID No.

1.

2. The method as described in claim 1, characterized in that, The nucleotide sequence of the gene An01g09210 is shown in SEQ ID No.

2.

3. The method as described in claim 1, characterized in that, The gene An01g09210 was knocked out in Aspergillus niger cells through genetic manipulation.

4. The recombinant strain obtained by the method according to any one of claims 1 to 3.

5. The method for hydrolyzing starch material using the recombinant strain as described in claim 4, characterized in that, The recombinant strain of claim 4 is cultured in the presence of starch raw material or starch inducer to hydrolyze starch.

Citation Information

Patent Citations

  • Recombination gene and method for increasing aspergillus niger expressed saccharifying enzyme

    CN103937766A

  • Aspergillus niger mutant strain with high yield of glucoamylase and industrial fermentation technology of aspergillus niger mutant strain

    CN105255741A

  • Saccharifying enzyme high-yield strain gene knockout recombinant bacteria with low trans-glycoside enzyme background as well as construction method and application thereof

    CN105969675A

  • New enzymes and methods for vanillic acid-related metabolic pathways

    EP4032900A1